LLP773_pLenti-6xHRBKET-sgRNA
(Plasmid
#211766)
-
PurposeMultiplexed gRNA plasmid targeting six different gene promoters (PACC1-2, EPCAM-2, B2M-4, KL-3, RBM3-1, HINT1-1), with mCherry selection
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 211766 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepLenti
-
Vector typeLentiviral
-
Selectable markersmCherry
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)NEB Stable
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert namegRNAs against six different human gene promoters (PACC1-2, EPCAM-2, B2M-4, KL-3, RBM3-1, HINT1-1)
-
gRNA/shRNA sequencePACC1-2: GGACCTACCGGCTCCGCG; EPCAM-2: GGGAGTTGGGGGAGTGAGT; B2M-4: GGGTAGGAGAGACTCACGC; KL-3: GGAGGCAGTCCCGGCTCGC; RBM3-1: GAAGACATCCGATCCAGCGG; HINT1-1: GACCAGGAACTTCCCCAAGC
-
SpeciesH. sapiens (human)
- Promoter pCMV and U6
Cloning Information
- Cloning method Gibson Cloning
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Also used GoldenGate cloning to insert multiple gRNA sequences.
Please visit https://www.biorxiv.org/content/10.1101/2022.07.01.498378v1 for bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
LLP773_pLenti-6xHRBKET-sgRNA was a gift from Ryan Lister (Addgene plasmid # 211766 ; http://n2t.net/addgene:211766 ; RRID:Addgene_211766) -
For your References section:
A modular dCas9-based recruitment platform for combinatorial epigenome editing. Swain T, Pflueger C, Freytag S, Poppe D, Pflueger J, Nguyen TV, Li JK, Lister R. Nucleic Acids Res. 2023 Nov 24:gkad1108. doi: 10.1093/nar/gkad1108. 10.1093/nar/gkad1108 PubMed 38000387